# SGS North America Inc. – FDA Inspection, Apr 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/c2f4967a-fdb0-46ab-b74d-e4b891e4c93f
Source feed: FDA_Inspections

> FDA inspection 1091237 of SGS North America Inc., April 24, 2019. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091237
- Company Name: SGS North America Inc.
- Inspection Date: 2019-04-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1308948 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/8d90b2b7-d7cd-44af-83c0-2f2c8c5e0215)
- FDA Inspection 1297328 - 2025-09-18
- [FDA Inspection 1194448 - 2023-01-10](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/9b9a1a03-ff8c-486c-a7b4-38376eee5aa2)
- FDA Inspection 1001725 - 2017-02-14
- [FDA Inspection 904043 - 2014-11-21](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/5457644a-8e46-4c5a-8330-b57b82593d46)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/sgs-north-america-inc/720655d2-660d-4355-81b5-bf1fb4da0a89

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c